Association of neprilysin polymorphism with cerebral amyloid angiopathy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 6, 2003, Pages 749-751

  Yamada, M ^a   Sodeyama, N ^b   Itoh, Y ^c   Takahashi, A ^c   Otomo, E ^c   Matsushita, M ^d   Mizusawa, H ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Yokufukai Geriatric Hospital   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE;

ADULT; AGED; AGING; AMYLOIDOSIS; ARTICLE; ASIAN; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; ETHNIC GROUP; GENETIC POLYMORPHISM; HUMAN; JAPAN; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEINS E; CEREBRAL AMYLOID ANGIOPATHY; CULTURE TECHNIQUES; FEMALE; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEPRILYSIN; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0038016644     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.6.749     Document Type: Article

References (26)

1. Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke 1987;18:311-24.
2. Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology 2000;20:8-22.
3. Greenberg SG, Rebeck GW, Vonsaltel JPG, et al. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-9.
4. Premkumar DRD, Cohen DL, Hedera P, et al. Apolipoprotein E ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996;148:2083-95.
5. Nicoll JAR, Burnett C, Love S, et al. High frequency of apolipoprotein E ε2 in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997;41:716-21.
6. Yamada M, Sodeyama N, Itoh Y, et al. Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke 1997;28:2219-21.
7. Yamada M, Sodeyama N, Itoh Y, et al. Association of α1-antichymotrypsin polymorphism with cerebral amyloid angiopathy. Ann Neurol 1998;44:129-31.
8. Calhoun ME, Burgermeister P, Phinney AL, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999;96:14088-93.
9. Urmoneit B, Prikulis I, Wihl G, et al. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab Invest 1997;77:157-66.
10. Weller RO, Massey A, Newman TA, et al. Cerebral amyloid angiopathy. Amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998;153:725-33.
11. Shinkai Y, Yoshimura M, Ito Y, et al. Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 1995;38:421-8.
12. Iwata N, Tsubuki S, Takaki Y, et al. Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 2000;6:143-50.
13. Takaki Y, Iwata N, Tsubuki S, et al. Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid β peptide in the brain. J Biochem 2000;128:897-902.
14. Iwata N, Tsubuki S, Takaki Y, et al. Metabolic regulation of brain Aβ by neprilysin. Science 2001;292:1550-2.
15. Akiyama H, Kondo H, Ikeda K, et al. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid β-protein (Aβ) deposition. Brain Res 2001;902:277-81.
16. Yasojima K, Akiyama H, McGeer EG, et al. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide. Neurosci Lett 2001;297:97-100.
17. Li C, Mooze RM, Hershi LB. Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs. J Biol Chem 1995;270:5723-8.
18. Haouas H, Morello D, Lavenu A, et al. Characterization of the 5′ region of the CD10/neutral endopeptidase 24.11 gene. Biochem Biophys Res Commun 1995;207:933-42.
19. Ishimaru F, Shipp MA. Analysis of the human CD10/neutal endopeptidase 24.11 promoter region: two separate regulatory elements. Blood 1995;85:3199-207.
20. Li C, Hersh LB. Characterization of the promoter region of the rat neprilysin gene. Arch Biochem Biophys 1998;358:189-95.
21. Sodeyama N, Yamada M, Itoh Y, et al. Lack of association of neprilysin polymorphism with AD and AD type neuropathological changes. J Neurol Neurosurg Psychiatry 2001;71:817-18.
22. Mirra S, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
23. Yamada M, Sodeyama N, Itoh Y, et al. No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy. Stroke 2002;33:896-900.
24. Yamada M, Tsukagoshi H, Otomo E, et al. Cerebral amyloid angiopathy in the aged. J Neurol 1987;234:371-6.
25. Comings DE, Dietz G, Johnson JP, et al. Association of the enkephalinase gene with low amplitude P300 waves. NeuroReport 1999;10:2283-5.
26. Oda M, Morino H, Maruyama H, et al. Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease. Neurosci Lett 2002;320:105-7.